Growth of calcium phosphate coating on Ti-7.5Mo alloy after anodic oxidation

Titanium and its alloys are widely used as biomaterials due to their mechanical, chemical and biological properties. To enhance the biocompatibility of titanium alloys, various surface treatments have been proposed. In particular, the formation of titanium oxide nanotubes layers has been extensively examined. Among the various materials for implants, calcium phosphates and hydroxyapatite are widely used clinically. In this work, titanium nanotubes were fabricated on the surface of Ti-7.5Mo alloy by anodization. The samples were anodized for 20 V in an electrolyte containing glycerol in combination with ammonium fluoride (NH4F, 0.25%), and the anodization time was 24 h. After being anodized, specimens were heat treated at 450 °C and 600°C for 1 h to crystallize the amorphous TiO2 nanotubes and then treated with NaOH solution to make them bioactive, to induce growth of calcium phosphate in a simulated body fluid. Surface morphology and coating chemistry were obtained respectively using, field-emission scanning electron microscopy (FEG-SEM), AFM and X-ray diffraction (XRD). It was shown that the presence of titanium nanotubes induces the growth of a sodium titanate nanolayer. During the subsequent invitro immersion in a simulated body fluid, the sodium titanate nanolayer induced the nucleation and growth of nano-dimensioned calcium phosphate. It was possible to observe the formation of TiO2 nanotubes on the surface of Ti-7.5Mo. Calcium phosphate coating was greater in the samples with larger nanotube diameter. These findings represent a simple surface treatment for Ti-7.5Mo alloy that has high potential for biomedical applications. © (2013) Trans Tech Publications, Switzerland.

A1 Noradrenergic Neurons Lesions Reduce Natriuresis and Hypertensive Responses to Hypernatremia in Rats

Noradrenergic neurons in the caudal ventrolateral medulla (CVLM; A1 group) contribute to cardiovascular regulation. The present study assessed whether specific lesions in the A1 group altered the cardiovascular responses that were evoked by hypertonic saline (HS) infusion in non-anesthetized rats. Male Wistar rats (280-340 g) received nanoinjections of antidopamine-β-hydroxylase-saporin (A1 lesion, 0.105 ng.nL-1) or free saporin (sham, 0.021 ng.nL-1) into their CVLMs. Two weeks later, the rats were anesthetized (2% halothane in O2) and their femoral artery and vein were catheterized and led to exit subcutaneously between the scapulae. On the following day, the animals were submitted to HS infusion (3 M NaCl, 1.8 ml • kg-1, b.wt., for longer than 1 min). In the sham-group (n = 8), HS induced a sustained pressor response (ΔMAP: 35±3.6 and 11±1.8 mmHg, for 10 and 90 min after HS infusion, respectively; P<0.05 vs. baseline). Ten min after HS infusion, the pressor responses of the anti-DβH-saporin-treated rats (n = 11)were significantly smaller(ΔMAP: 18±1.4 mmHg; P<0.05 vs. baseline and vs. sham group), and at 90 min, their blood pressures reached baseline values (2±1.6 mmHg). Compared to the sham group, the natriuresis that was induced by HS was reduced in the lesioned group 60 min after the challenge (196±5.5 mM vs. 262±7.6 mM, respectively; P<0.05). In addition, A1-lesioned rats excreted only 47% of their sodium 90 min after HS infusion, while sham animals excreted 80% of their sodium. Immunohistochemical analysis confirmed a substantial destruction of the A1 cell group in the CVLM of rats that had been nanoinjected withanti-DβH-saporin. These results suggest that medullary noradrenergic A1 neurons are involved in the excitatory neural pathway that regulates hypertensive and natriuretic responses to acute changes in the composition of body fluid. © 2013 da Silva et al.

Nanostructured materials based on mesoporous silica and mesoporous silica/apatite as osteogenic growth peptide carriers

The aim of this work was the preparation of inorganic mesoporous materials from silica, calcium phosphate and a nonionic surfactant and to evaluate the incorporation and release of different concentrations of osteogenic growth peptide (OGP) for application in bone regeneration. The adsorption and release of the labeled peptide with 5,6-carboxyfluorescein (OGP-CF) from the mesoporous matrix was monitored by fluorescence spectroscopy. The specific surface area was 880 and 484 m2 g- 1 for pure silica (SiO) and silica/apatite (SiCaP), respectively; the area influenced the percentage of incorporation of the peptide. The release of OGP-CF from the materials in simulated body fluid (SBF) was dependent on the composition of the particles, the amount of incorporated peptide and the degradation of the material. The release of 50% of the peptide content occurred at around 4 and 30 h for SiCaP and SiO, respectively. In conclusion, the materials based on SiO and SiCaP showed in vitro bioactivity and degradation; thus, these materials should be considered as alternative biomaterials for bone regeneration. © 2013 Elsevier B.V.

Obtenção de fosfatos de cálcio pelo método biomimético sobre a superfície da liga Ti-6Al-4V modificada pelo laser Nd:YAG

In this work, surface modification of the Ti-6Al-4V alloy by irradiation with a Nd:YAG laser beam was studied. The matrix spacing was varied and the other parameters were kept constant. After theirradiation, the samples were immersed into SBF solution (Simulated Body Fluid) for 7 days at 37 ° C for nucleation and formation of calcium phosphates. After this period, the samples were subjected to a heat treatment at 600 °C. X-ray diffraction results indicated the formation of a mixture of phases containing hydroxyapatite and tricalcium phosphate. Infrared analysis demonstrated the presence of bands related to hydroxyapatite. SEM micrographs showed that different matrix spacing used leads to the formation of different morphologies.The 0.01 cm spacing induced the formation of microspheres, characteristic of the hydroxyapatite phase, while for 0.02 cm spacing, only a non-homogeneous coating was obtained. Therefore, the use of laser in the production of active surfaces for deposition of bioceramics proved to be viable, and the final coating has potential for applications in the field of dental implants.

Síntese de nanopartículas de sílica mesoporosa e aplicações como biomaterial

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Avaliação de implantes dentários da liga experimental Ti-30Ta após tratamento de superfície biomimético e imobilização com bisfosfonato

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Desenvolvimento de superfícies ativas na ligaTi-15Mo para aplicação como biomaterial

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Estudo da solubilidade de apatitas em meios de interesse biológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Avaliação do tratamento térmico em recobrimentos cerâmicos bioativos pelo método biomimético sobre titânio c.p. modificados pelo laser Nd:YAG

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Recobrimento de apatitas empregando-se o método biomimético: estudo da influência dos íons K+, Mg2+, SO42- e HCO3- na formação de hidroxiapatita

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Preparação de superfície bioativa na Liga Ti-7,5Mo para uso em Odontologia

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Relação entre o corpo gorduroso e a vitelogênese em fêmeas de Melipona quadrifasciata anthidioides Lep

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Biocompatilibidade in vivo de implantes de titânio submetidos ao processo biomimético

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Participação do grupamento catecolaminérgico A2 do núcleo do trato solitário comissural nos ajustes cardiovasculares e do equilíbrio hidroeletrolitíco induzidos por alterações da osmolaridade ou volume plasmático

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Plataforma inorgânica a base de apatitas de interesse biológico visando à liberação controlada de fármacos

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)